ITIC's Q2 earnings jump 38% year over year with double-digit revenue growth, driven by higher real estate activity and gains from non-title services.

CCJ posts Q2 revenue growth of 47% and EPS rise of 410%, fueled by uranium volume gains and strong Westinghouse earnings.

President Donald Trump leaned on a big bank's CEO on Tuesday, a day after appearing to make peace with a chipmaking chief.

The report showed that Saudi Arabia raised production by 170,000 bpd in July.

Organon shares are very cheap, but weak growth, high debt, and a lack of clear catalysts make them a value trap rather than a bargain. Revenue is stagnating as new products only offset legacy declines; cost-cutting helps margins, but can't reverse the downward trend in earnings. Valuation discounts already reflect worst-case scenarios; fair value is around $9 per share, leaving little upside unless growth drivers emerge.

A.O. Smith expands water treatment reach with key acquisitions, boosts margins and maintains strong liquidity despite regional challenges.

BigBear.ai shares plunge 31.2% as Q2 revenues drop 18% Y/Y and the 2025 sales outlook is cut on Army program weakness.

OPEN's agent-led model boosts listing conversions 5x, with 2026 gains expected as the initiative scales.

Eastman Kodak, one of the most iconic American companies, known for its photography and film business, said it is at risk of going out of business, prompting a massive stock slide on Tuesday.

PHILADELPHIA , Aug. 12, 2025 /PRNewswire/ -- Berger Montague PC is investigating potential securities fraud claims on behalf of investors of CTO Realty Growth, Inc. (NYSE: CTO) ("CTO" or the "Company") following the filing of a securities class action lawsuit on behalf of investors who purchased or otherwise acquired CTO securities between February 18, 2021 through June 24, 2025 (the "Class Period"). Investor Deadline: Investors who purchased or acquired CTO securities during the Class Period may, no later than October 7, 2025 , seek to be appointed as a lead plaintiff representative of the class.

BKV Corporation (NYSE:BKV ) Q2 2025 Earnings Conference Call August 12, 2025 10:00 AM ET Company Participants Christopher Pungya Kalnin - CEO & Director David Robert Tameron - Chief Financial Officer Eric S. Jacobsen - President of Upstream Conference Call Participants Christopher Moore Baker - Evercore ISI Institutional Equities, Research Division Geoff Jay - Daniel Energy Partners, LLC Jacob Phillip Roberts - Tudor, Pickering, Holt & Co. Securities, LLC, Research Division Jonathan S.

The U.S. Food and Drug Administration (FDA) on Tuesday approved Insmed Incorporated's INSM Brinsupri (brensocatib 10 mg and 25 mg tablets). It is an oral, once-daily treatment for non-cystic fibrosis bronchiectasis (NCFB) in adults and children 12 years and older.

Anthony Chukumba, Loop Capital managing director, joins 'The Exchange' to discuss upgrading Five Below to a buy.

KMT faces segment weakness, high debt and forex headwinds, causing earnings estimate cuts and stock underperformance.

CWCO posts a 60% second-quarter EPS beat and 6.3% year-over-year revenue growth, driven by stronger retail sales.

MMM's Transportation and Electronics unit posts 1% revenue growth in Q2 2025, fueled by aerospace and electronics gains despite market headwinds.

ENPH shares slump 28.2% in three months amid weak demand, higher costs and policy changes pressuring growth.

HON sees robust demand in Building Automation, with strong sales growth in North America, the Middle East and key verticals.

A new AGA-sponsored survey conducted by The Harris Poll, a Stagwell (STGW) agency, reveals that IBS symptoms disrupt patients' productivity and personal activities 19 days each month, impacting both personal and professional life BETHESDA, Md. , Aug. 12, 2025 /PRNewswire/ -- Despite social media helping to increase awareness of irritable bowel syndrome (IBS) among the public (81% of health care providers agree) and advancements in treatment over the past decade, IBS symptoms continue to significantly impact patients' daily lives and productivity, according to a new survey released by the American Gastroenterological Association (AGA), in partnership with The Harris Poll, a …

NEW YORK, Aug. 12, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Reddit, Inc. (NYSE: RDDT) between October 29, 2024 and May 20, 2025, both dates inclusive (the “Class Period”), of the important August 18, 2025 lead plaintiff deadline.